Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cGMP regulated processes

Details for Australian Patent Application No. 2002319296 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 101 35 815.6 23.07.01 DE

29 May 2003 Application Open to Public Inspection

Published as AU-B-2002319296

30 August 2007 Application Accepted

Published as AU-B-2002319296

3 January 2008 Standard Patent Sealed

14 May 2009 Assignment Registered

Bayer HealthCare AG The patent has been assigned to Bayer Schering Pharma Aktiengesellschaft

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.